Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DYRK2 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
mRNA | TOR3A | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
mRNA | SLAMF1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
mRNA | ZNF579 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
mRNA | C20orf202 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
mRNA | OGFR | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
mRNA | SLC25A37 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
mRNA | PELI1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
mRNA | BCS1L | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
mRNA | ZSCAN4 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |